The Institut Pasteur and the International Vaccine Institute (IVI) are strengthening their commitment to global health by signing a Memorandum of Understanding (MoU), marking a new milestone in their collaboration. The official ceremony took place on December 19, 2024, on the Institut Pasteur campus in Paris, in the presence of Yasmine Belkaid, Director General of the Institut Pasteur, and Dr. Jerome Kim, Director General of IVI.
This protocol outlines an expanded framework for collaboration across several strategic areas:
• Development of joint scientific projects: The two institutions will combine their expertise to conduct cutting-edge research, particularly on the development of innovative vaccines.
• Funding acquisition: Efforts will be combined to mobilize resources to support collaborative projects in the field of vaccines.
• Enhancing methodologies in clinical studies: Teams will work together to improve protocols and scientific approaches for rigorous and standardized clinical evaluations.
• Technical and scientific support: The agreement includes cross-participation in vaccine-related scientific committees, enabling expertise sharing and better coordination of efforts.
This strategic partnership between two major players in biomedical research and public health is part of an international effort to combat infectious diseases. By joining forces, the Institut Pasteur and IVI aim to accelerate the development of vaccine solutions to prevent and control epidemics worldwide.
